BioNumerik Pharmaceuticals

Curated by Signal

Developer of drugs for the treatment of cancer

Life Sciences Technologybionumerikpharma.com

Overview

Developer of drugs for the treatment of cancer. The companys pipeline includes drug candidates, Tavocept and BNP1350 for both oncology and non-oncology indications. It has a multi-disciplinary technology platform to integrate chemistry, biology, and quantum physics for research and development.

Key facts

Founded: 1992
Headquarters: San Antonio, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

DataPool
Provider of legal DNA test, employee drug & alcohol testing services
Life Sciences TechnologyRichmond, United States
Laxmi Therapeutic Devices
Develper of a wearable diagnostic device for continuous glucose monitoring
Life Sciences TechnologyGoleta, United States
Aprecia Pharmaceuticals
Develops & manufactures orodispersible formulations of highly prescribed high-dose medications using proprietary drug delivery systems.
Life Sciences TechnologyLanghorne, United States

About BioNumerik Pharmaceuticals

What does BioNumerik Pharmaceuticals do?

Developer of drugs for the treatment of cancer.

Where is BioNumerik Pharmaceuticals headquartered?

BioNumerik Pharmaceuticals is headquartered in San Antonio, United States.

When was BioNumerik Pharmaceuticals founded?

BioNumerik Pharmaceuticals was founded in 1992.

Which sector is BioNumerik Pharmaceuticals in?

BioNumerik Pharmaceuticals operates in Life Sciences Technology.

Who are BioNumerik Pharmaceuticals's competitors?

Companies similar to BioNumerik Pharmaceuticals include DataPool, Laxmi Therapeutic Devices, and Aprecia Pharmaceuticals.